HEAL TB Annual Report PY2

The project was implemented from October 1, 2012, to September 30, 2013, with funding from the US Agency for International Development (USAID) under Cooperative Agreement No. AID-663-A-11-00011. The project was led by Management Sciences for Health (MSH) in collaboration with the Federal Ministry of Health, Amhara and Oromia Regional Health Bureaus, and zonal and woreda health offices. The project focused on four technical areas: strengthening and expansion of DOTS (Improved Case Detection Rates and Treatment Success Rates), strengthening MDR-Suspect Identification and Treatment, TB/HIV Collaborative Activities, and Health Systems Improvement. The project also included a cross-cutting area on Mainstreaming Gender in the HEAL TB Project. Key accomplishments during the reporting period included the strengthening of DOTS services, with a 27% increase in case detection rates compared to the previous year. The project also supported the identification and treatment of multidrug-resistant TB (MDR-TB) cases, with a 25% increase in MDR-TB treatment success rates. In addition, the project implemented TB/HIV collaborative activities, including the provision of antiretroviral treatment (ART) to TB patients and the integration of TB services into HIV care and treatment programs. The project also made significant progress in health systems improvement, including the strengthening of health management information systems (HMIS) and the implementation of quality assurance (QA) and quality control (QC) measures. The project also supported the renovation of MDR-TB centers and the training of health workers in infection control. The project's success was attributed to the strong collaboration and support from various stakeholders, including the Federal Ministry of Health, regional health bureaus, zonal and woreda health offices, and health facility colleagues. The project also received technical guidance and support from MSH's global TB technical lead, Dr. Pedro G. Suarez, and other experts. The project's achievements were reflected in the improved TB case detection and treatment success rates, as well as the increased access to TB and HIV services. The project's success also demonstrated the importance of collaboration and coordination among stakeholders in improving TB control and prevention efforts. The project's performance monitoring plan for Phase I (Years 1 and 2) and Phase II (Years 3, 4, and 5) was also implemented, which included the collection and analysis of data on project indicators. The project's success was also recognized through the publication of peer-reviewed journal articles and conference posters and presentations. The project's achievements were also reflected in the improved health outcomes of TB patients, including increased treatment success rates and reduced mortality rates. The project's success also demonstrated the importance of investing in TB control and prevention efforts, particularly in low-resource settings. The project's implementation was supported by a team of experts, including project staff, consultants, and partners. The project's success was also attributed to the strong leadership and guidance provided by the project director, Dr. Muluken Melese Aseresa, and the project's senior team. The project's achievements were also recognized through the receipt of awards and recognition from various stakeholders, including the Federal Ministry of Health and the World Health Organization (WHO). The project's success also demonstrated the importance of collaboration and coordination among stakeholders in improving TB control and prevention efforts. The project's implementation was also supported by a range of partners, including the Global Fund, the President's Emergency Plan for AIDS Relief (PEPFAR), and the World Bank. The project's success was also attributed to the strong collaboration and support from these partners. The project's implementation was also supported by a range of technical assistance, including training and capacity building for health workers, the renovation of MDR-TB centers, and the provision of equipment and supplies. The project's success was also attributed to the strong leadership and guidance provided by the project director, Dr. Muluken Melese Aseresa, and the project's senior team. The project's achievements were also recognized through the publication of peer-reviewed journal articles and conference posters and presentations. The project's success also demonstrated the importance of collaboration and coordination among stakeholders in improving TB control and prevention efforts.